The objectives of HEEHD 2019 are to:
- Analyze barriers preventing HBCUs from securing significant funding awards or translating research results to address health disparities in minority populations.
- Facilitate scientific discussion to devise effective methods for improving biomedical Research and Development (R&D); Innovation; Entrepreneurship; and Award management training for HBCUs so that faculty and assisting students (i.e. next generation of biomedical researchers), are equipped with proficient skills to significantly increase NIH grant/contract awards and address health disparities with commercialized technology-transfer.
- Facilitate policy discussions with federal and state governments, industry, and Non-Governmental Organizations (NGOs) on how HBCUs can effectively apply their HEEHD training to address health disparities by leveraging cross government, organizational, and industry resources.
Hence, the 1st annual HBCUs Eradicate Economic and Health Disparities (HEEHD) 2019 Conference will address, directly, the aforementioned disparities.
HEEHD 2019 invites empirical research and concept papers, from HBCUs, African American biomedical companies, and relevant organizations/agencies focused on techniques & methods that effectively facilitate innovative research and development; technology transfer; and resulting product/service commercialization to address the aforementioned economic and health disparities within and among minority populations.
The proposed HEEHD 2019 conference will provide an engaging forum, conducive for HBCU faculty and graduate students, to learn and further develop capabilities to secure biomedical related R&D funding; effectively manage translational R&D funding efforts; improve technology transfer infrastructure; and generate IP license revenue to continually develop solutions that eradicate U.S. economic and health disparities. The HEEHD 2019 conference will also facilitate a forum to identify mentors for undergraduate students who desire to learn the skills that contribute to this biomedical innovation ecosystem.
This translational R&D oriented paradigm shift, for HBCUs, has potential to improve the scientific knowledge of how innovative interventions, to prevent or mitigate health disparity, are executed.
This tactical strategy has potential to economically sustain HBCUs through technology transfer licensing revenue; galvanize a cooperative mission to address persistent economic and health disparities through innovations (i.e., generated by HBCUs); and continue to achieve HBCU’s initial mission of serving the educational needs of minority American faculty, students, and communities since their first establishment in 1837.